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ith IMP, positives (inhibition ≥7 mm) conﬁrmed by IMP +
DTA Etest and PCR (VIM and IMP genes).
Results: Of the 75 PSA isolates, 12(16%) were MBL
roducers. Diabetes mellitus was found to be the major risk
actor in PSA infections. Overall resistance to CIP 50.7%>
ZD 37.3% >AK 36%> FEP 34.7%. Resistance pattern among
BL/NMBL was CZD(91.7%/23.8%), FEP(91.7%/20.6%),
ZP(91.7%/15.9%), TIM(100%/27%), GEN(100%/23.8),
K(100%/20.6%), CIP(100%/38.1%), IMP(100%/6.3%),
EM(75%/9.5%), ATM(91.7%/38.1%). Resistance to IMP
nd MEM was 22.7% and 21.3% respectively. All isolates
ere susceptible to CL. MDR (resistant to ≥2 classes of
ntimicrobials) was 34(45.3%).Overall 14(18.7%) were CDDT
ositive. IMP + EDTA Etest and PCR conﬁrmed 12 to be MBL
ositives. Among the MBL isolates, one was also positive
or IMP gene, which on sequencing was conﬁrmed to be
MP 7. Sensitivity and speciﬁcity of CDDT was 100% and
6.8% respectively when compared to PCR. History of prior
ntibiotic usage of aminoglycosides (66.7%), 3rd generation
ephalosporins (58.3%), quinolones (58.3%), carbapenems
50%), penicillins (25%), betalactam + betalactamase
nhibitors (8.3%) was noted for the patients with MBL
nfection. Clinical improvement or cure with modiﬁcation
f initial antibiotics was found in 63.6% (7/11) patients with
BL PSA.
CR for VIM and IMP gene in PSA
onclusion: MBL production is an important mechanism of
ARB-R among PSA. Spread should be further minimized by
sing carbapenems judiciously in the treatment of PSA infec-
ions. CDDT is a useful method for screening MBL. VIM type
f MBL was seen among all MBL positive isolates.
oi:10.1016/j.ijid.2010.02.1557
l
A
a
C
f
o
f
P
o
s
d
f
i
c
e
dternational Congress on Infectious Diseases (ICID) Abstracts
3.002
he resistance patterns of Pseudomonas aeruginosa in
ospitals from Greece and Romania and its importance for
he therapy of nosocomial infections and infection control
ractices
.M. Junie1,∗, S. kastanakis2, M. Petrascu1, C. Bobos¸ 1, A.
souri 2, P. Karagianni2, E. Papadomanolaki 2, G. Aleuraki 2,
. Gatzima2, I. Varthalitis 3
University of Medicine and Pharmacy, Cluj Napoca, Roma-
ia
St. George General Hospital, Chania, Greece
Infection Control Committee, Chania, Greece
Background: One of the most difﬁcult problems in
ospitals is the appearance of an increased number of Pseu-
omonas antibiotic resistant strains. The objective of our
tudy is to describe the resistance pattern of Pseudomonas
eruginosa strains.
Methods: For isolating Pseudomonas aeruginosa strains,
he usual nutritive media were used. Identiﬁcation was
ade with Vitek2 system (BioMerieux). The susceptibility
o the antibiotics of strains was performed by Kirby Bauer
ethod as recommended by CLSI and Vitek2 system. Were
ested 229 strains isolated from urine and surgical wounds,
n Cluj Napoca, Romania, and 36 strains isolated from blood
amples in Chania, Greece. The majority of the strains
86.1%) were isolated from patients in wards and a percent-
ge of 13.8 from Intensive Care Unit.
Results: The strains isolated in Romania from urine
howed a high resistance to betalactamins, remaining sus-
eptible to Carbenicillin, Carbapenems, Ceftazidime and
efepime. Over 80% of the strains, were resistant to oth-
rs of third generation cephalosporins. The strains isolated
rom blood, presented resistance to Aztreonam (30.43%)
nd Ceftazidime (13%). 13% were resistant to Imipenem
nd Meropenem. Pseudomonas aeruginosa isolated strains
n Romania, showed resistance to Amikacin (71.4% iso-
ated strains from urine and 29.7% from surgical wounds),
nd a low resistance to Gentamycin (18.6%), Tobramycin
25%). 29.6% were resistant to Colistin. The strains iso-
ated in Chania, showed resistance to Gentamycin (21.4%).
ll strains isolated from urine, were resistant to Peﬂoxacin
nd a high resistance was detected to Nalidixic acid (75%),
iproﬂoxacin (75%) and Oﬂoxacin (50%). The strains isolated
rom surgical wounds, presented a resistance to quinolones,
scillating between 33.1% and 51.9%. The isolated strains
rom blood showed resistance to Nalidixic acid (38.5%),
eﬂoxacin (38.5%) and Ciproﬂoxacin (38.5).
Conclusion: Our results could reﬂect the implication
f some hospital multi resistant Pseudomonas aeruginosa
trains in nosocomial infections. In Greece, a decline in
rugs resistance of Pseudomonas strains has been noted. As a
act, it is rather encouraging, and probably we can attribute
t to adherence to infection control practices and prudent
hemotherapeutic agents use as proposed by Infectious Dis-
ases Control Committee. The majority of the strains was
etected in ward patients and owing to reduced morbidity
trac
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t14th International Congress on Infectious Diseases (ICID) Abs
factors compared with patients in ICU, the reduced resis-
tance to antibiotics can be explained.
doi:10.1016/j.ijid.2010.02.1558
23.003
Extended spectrum -lactamase production at the Komfo
Anokye Teaching Hospital, Kumasi, Ghana
Y. Adu-Sarkodie
School of Medical Sciences, KUMASI, Ghana
Background: In recent times enterobacteriaceae iso-
lated at the Komfo Anokye TeachingHospital (KATH) have
shown signiﬁcant resistance to 2nd and 3rd generation
cephalosporins. In 2006, 18-32% of all enterobacteriaceae
isolated from urine and blood were resistant to the
cephalosporins cefuroxime, ceftriaxone, ceftazidime and
cefotaxime. These antibiotics are the mainstay for the
treatment of severe infections in the hospital. Microbial
resistance to these antibiotics if due to the production
of Extended spectrum -lactamases (ESBL) may also indi-
cate resistance to the ﬂuoroquinolones, aminoglycosides
and other antibiotics. This limits therapeutic options for the
treatment of severe infections. We studied the extent of
ESBL production amongst Klebsiella sp and E. Coli at KATH.
Methods: ESBL production in 300 non-selected, non-
duplicate isolates of Klebesiella sp and E.coli obtained from
blood, urine, wounds, and sputum of both in-patients and
out-patients was determined by the combined disc method
using ceftazidime, ceftriaxone and cefpodoxime discs singly
and in combination with clavulanic acid.
Results: 44% and 55% respectively of E.coli and Kleb-
siella sp (57.8% K.pneumo,) were ESBL producers. ESBL
production in the organisms was commoner in in-patients
(75.4%) than out-patients (24.6%), though not statistically
signiﬁcant (OR=1.40, 95% CI 0.79-2.46, p=0.31). In gen-
eral, ESBL producing organisms apart from being resistant
to cephalosporins were also resistant to gentamicin and
ciproﬂoxacin. They were however susceptible to the car-
bapenems.
Conclusion: The high level of ESBL production found in
these enterobacteriaceae with the resultant microbial resis-
tance to available cephalosporins and other agents implies
difﬁculties with the choice of therapeutic options for the
treatment of severe infections. Carbapenems are expen-
sive on the Ghanaian market and their use in non-severe
infections (as may be suggested by these results) may be
inappropriate. Both prescribers and pharmaceutical agents
will need to reﬂect soberly on their contribution to this sor-
did state of affairs. We need to put an end to our practice
of cracking nuts with sledge hammers!
doi:10.1016/j.ijid.2010.02.1559
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ntimicrobial susceptibility proﬁle of Pseudomonas
eruginosa strains isolated at a tertiarycare University
ospital (S. Orsola Hospital, Bologna, Italy)
. Manfredi
University of Bologna, Bologna, Italy
Background: The increased rate of antimicrobial resis-
ance among Gram-negative bacilli and Enterobacteriaceae
s a general concern,especially in the hospital setting.A
rospective microbiological monitoring including a contin-
ed surveillance of antimicrobial susceptibility rates of all
elevant pathogens,is ongoing at our Hospital.
Methods: The temporal variations of in vitro antimicro-
ial sensitivity rates were registered at quarterly intervals
or all suitable Pseudomonas aeruginosa strains,during the
ear 2008.The same pathogen cultured more than once from
he same patient within one month,has been considered
nce.
Results: Among Pseudomonas aeruginosa isolates
494 strains tested on the whole), the best perfor-
ance was obtained by the old colistin (colimycin),with
100% susceptibility rate, followed by piperacillin-
azobactam (73.9-78.6.4% of tested strains),amikacin
71.7-84.5% of tested strains),imipenem (69.9-79.1%
f tested strains),ceftazidime (from 68.0 to 82.5% of
ested strains),tobramycin (from 63.0 to 76.4% of tested
trains).On the other hand,signiﬁcantly less effective
ensitivity proﬁles were shown by gentamicin (57.5% to
1.3% of tested strains),ciproﬂoxacin (51.3-68.0% of tested
trains),aztreonam (59.5-61.2% of tested strains),ticarcillin-
lavulanate (54.2-66.9%),and mezlocillin (45.3-54.2% of
ested strains).When examining temporal trends of
ntibiotic sensitivity ﬁgures in the examinewd period
January-December 2008), signiﬁcantly favorable changes
ere observed only for ceftazidime and ciproﬂoxacin (p <
025).
Conclusion: A prospective surveillance study of antimi-
robial susceptibility rates of a major hospital-associated
rganism like Pseudomonas aeruginosa is of remarkable
mportance, to establish reliable guidelines of antibi-
tic treatment and prophylaxis, on local-regional basis.
iperacillin-tazobactam, amikacin,imipenem,and the same
eftazidime still maintain a reliable role in eventual,empiric
egimens to be added pendingmicrobial isolation and in vitro
usceptibility studies,since they remained active in nearly
0% of hospital isolates of the last year 2008.Colistin main-
ained full in vitro activity against all Pseudomonas strains
bserved over time. An appreciable increase of sensitivity
ates to ceftazidime and ciproﬂoxacin was also observed
ver the last year 2008.
oi:10.1016/j.ijid.2010.02.1560
